Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €12.84 EUR
Change Today +0.34 / 2.72%
Volume 683.0K
As of 11:35 AM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Irina Staatz-Granzer

Vice Chairman of Supervisory Board, Member of Transactions Committee and Member of Audit Committee,Innate Pharma S.A.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 3 different industries.

See Board Relationships


Mrs. Irina Staatz-Granzer served as the Co-Chief Executive Officer of U3 Pharma AG. Mrs. Staatz-Granzer founded and serves as Chief Executive Officer of Staatz Business Dev elopment & Strategy and within this frame organised the trade sale of U3 Pharma to Daiichi Sankyo in 2008. She served several positions in the pharmaceutical industry, mostly in Business Development at Hermal, Boots Healthcare International, Knoll, Scil Biomedicals and as Chief Executive Officer (Scil ...

Read Full Background

Corporate Headquarters*

117, Avenue de Luminy
Marseille, Provence-Alpes-Côte d'Azur 13009


Phone: 33 4 30 30 30 30
Fax: 33 4 30 30 30 00

Board Members Memberships*

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPH:FP €12.84 EUR +0.34


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INNATE PHARMA SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at